fluorouracil has been researched along with Minimal Disease, Residual in 153 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For patients who have significant residual tumor after resection or relapse after radiation, the proper chemotherapy regimen has not yet been identified." | 6.72 | Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. ( Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS, 2006) |
| "Sequential doxorubicin/paclitaxel (AT) followed by CMF treatment was shown to be an active neoadjuvant chemotherapy regimen in the first European Cooperative Trial in Operable Breast Cancer (ECTO I trial)." | 5.16 | Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II). ( Bari, M; Ciruelos, E; De Benedictis, E; Dittrich, C; Gaion, F; Gomez, P; Lluch, A; Luca, G; Mansutti, M; Morandi, P; Pavesi, L; Semiglazov, V; Valagussa, P; Zamagni, C; Zambetti, M, 2012) |
| " Surgery Division of Verona University, 155 consecutive patients with locally advanced esophageal cancers (90 SCC, 65 adenocarcinoma) were treated with a single protocol of neoadjuvant CRT (docetaxel, cisplatin, and 5-fluorouracil with 50." | 3.79 | Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center. ( Casella, F; de Manzoni, G; Giacopuzzi, S; Pasini, F; Verlato, G; Weindelmayer, J; Zanoni, A; Zhao, E, 2013) |
| "We included 199 patients with HER2+ breast cancer from three successive cohorts of neo-adjuvant chemotherapy on the basis of paclitaxel (Taxol) (P) administered weekly (w) or three weekly (3-w), followed by 5-fluorouracil (F), doxorubicin (A) or epirubicin (E), and cyclophosphamide (C)." | 3.74 | Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab. ( Buzdar, AU; Dawood, SS; Esteva, FJ; Gonzalez-Angulo, AM; Green, MC; Hatzis, C; Hortobagyi, GN; Kuerer, HM; Mejia, JA; Peintinger, F; Pusztai, L; Symmans, WF, 2008) |
| "Resection specimens from 47 cases of oesophageal adenocarcinoma treated with preoperative 5-fluorouracil/cisplatin and radiotherapy were reviewed." | 3.71 | A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. ( Dunne, B; Griffin, M; Kelly, A; Mulligan, E; Reynolds, JV, 2001) |
| "IC with paclitaxel or FAC resulted in effective downstaging of primary tumors and axillary metastases in patients with Stage IIA, IIB, and IIIA breast carcinoma." | 3.70 | The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. ( Ames, FC; Buzdar, AU; Feig, BW; Hunt, KK; Lenert, JT; Mirza, NQ; Ross, MI; Singletary, SE; Vlastos, G, 2000) |
| "Patients with stage II or stage IIIC colon cancer with positive ctDNA results (tested as standard of care with commercial testing) will be eligible for enrollment in cohort B." | 3.11 | Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US. ( Dasari, A; Deming, D; George, TJ; Kopetz, S; Lieu, CH; Lin, Y; Lucas, PC; Sahin, IH; Yothers, G, 2022) |
| "In the remaining seven (20%), the residual tumour clinically appeared benign." | 2.82 | Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign. ( Bujko, K; Malinowska, M; Mroz, A; Pietrzak, L; Rupinski, M; Rutkowski, A; Szczepkowski, M; Wyrwicz, L, 2016) |
| "Overall accuracy of the residual cancer burden score determination was 0." | 2.80 | Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. ( Albarracin, C; Downs-Kelly, E; Gould, R; Hatzis, C; Morkowski, J; Peintinger, F; Sinn, B; Symmans, WF, 2015) |
| "Patients with cT3-4, any N, any M rectal cancer were eligible." | 2.79 | Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer. ( Birnbaum, E; Fleshman, J; Gao, F; Hall, L; Hunt, S; Kodner, I; Lockhart, AC; Mutch, M; Myerson, RJ; Naughton, M; Olsen, J; Parikh, P; Picus, J; Rigden, C; Safar, B; Sorscher, S; Suresh, R; Tan, B; Wang-Gillam, A, 2014) |
| "The presence of residual tumour by conventional imaging, dichotomised as positive or negative, and the level of FDG uptake (standardised uptake values, SUV) were compared with histopathology, which served as the reference standard." | 2.75 | Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer. ( Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C, 2010) |
| "Patients with advanced esophageal squamous cell carcinoma receive neoadjuvant chemotherapy or chemoradiotherapy to improve survival, but benefits are observed only in those with histologic response." | 2.73 | Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. ( Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T, 2008) |
| "For patients who have significant residual tumor after resection or relapse after radiation, the proper chemotherapy regimen has not yet been identified." | 2.72 | Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. ( Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS, 2006) |
| "Approximately 1 out of 10 advanced rectal cancers after preoperative radiotherapy or radiochemotherapy was characterized by DIS of over 5 mm." | 2.72 | Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study. ( Bujko, K; Chmielik, E; Huzarski, T; Karmolinski, A; Kepka, L; Majewski, P; Nasierowska-Guttmejer, A; Nowacki, MP; Sopylo, R; Sygut, J; Wandzel, P; Wojnar, A, 2006) |
| "Forty patients with locally advanced breast carcinoma underwent neoadjuvant chemotherapy." | 2.71 | Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. ( Arbion, F; Body, G; Brunereau, L; Chapiron, C; Denis, F; Desbiez-Bourcier, AV, 2004) |
| "Peritoneal carcinomatosis in the absence of distant metastasis occurs in approximately 8 per cent of patients with colorectal cancer." | 2.71 | Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. ( van Ruth, S; van Tinteren, H; Verwaal, VJ; Zoetmulder, FA, 2004) |
| "Clinical response and residual tumor size were evaluated in 108 treated patients who completed a clinical trial with paclitaxel and then received combined 5-fluorouracil, doxorubicin, and cyclophosphamide chemotherapy." | 2.71 | Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. ( Buzdar, AU; Fiterman, DJ; Frye, D; Gal-Gombos, E; Green, M; Hortobagyi, GN; Kuerer, H; Poniecka, A; Pusztai, L; Rajan, R; Rouzier, R; Smith, TL; Symmans, WF; Whitman, G; Yang, Y, 2004) |
| "All patients had surgically documented minimal residual disease (1." | 2.68 | Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial. ( Averette, H; Berek, JS; Blessing, JA; Braly, PS; Homesley, HD, 1995) |
| "Treatment of both Hodgkin's disease (HD) and high-grade non-Hodgkin's lymphoma (HG-NHL) with bulky presentation at diagnosis frequently results in residual masses detected radiologically." | 2.68 | Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. ( Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M, 1996) |
| "Patients with residual tumor on posttreatment biopsy were treated with a salvage regimen that consisted of additional pelvic RT (9 Gy), 5-FU, and cisplatin (100 mg/m2)." | 2.68 | Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. ( Coia, L; Doggett, S; Flam, M; John, M; Kerman, H; Murray, K; Myerson, R; Pajak, TF; Petrelli, N; Quivey, J; Rotman, M, 1996) |
| "Treatment of esophageal cancer has been primarily palliative." | 2.68 | Treating esophageal cancer with a combination of chemotherapy, radiation, and excision. ( Bates, DM; Clyde, JC; Garcia, JM; Girvin, GW; Lin, PH; Matsumoto, GH, 1995) |
| "The majority of anal cancers are squamous cell carcinomas, and they are treated according to stage." | 2.52 | Anal cancer treatment: current status and future perspectives. ( Abdayem, P; Antoun, J; Ghosn, M; Kourie, HR; Nasr, D, 2015) |
| "From a global perspective, gastric cancer including cancer of the esophago-gastric junction is the fourth most common malignant tumor and the second-most common cause of cancer-related death." | 2.46 | [Diagnosis and treatment of gastric cancer]. ( Ebert, M; Grenacher, L; Lordick, F; Moehler, M; Röcken, C; Schumacher, G, 2010) |
| "Eighty percent of the patients had squamous cell carcinoma and 20% had adenocarcinoma." | 2.39 | Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. ( Bates, BA; Bernard, SA; Detterbeck, FC; Qaqish, BF; Tepper, JE, 1996) |
| "When treating invasive basal cell carcinoma (BCC) with Mohs micrographic surgery (MMS), including infiltrative and nodular subtypes, the goal is complete surgical removal of the tumor." | 1.56 | Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery. ( Housewright, C; Pederson, H; Staples, CJ, 2020) |
| "Pathologists assess rectal cancers that have responded significantly to neoadjuvant therapy more thoroughly." | 1.51 | Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation. ( Avila, K; Chow, OS; Chu, P; Garcia-Aguilar, J; Keskin, M; Patil, S; Shia, J; Smith, DD; Smith, JJ; Widmar, M, 2019) |
| "Management of advanced intrahepatic cholangiocarcinoma (iCCA) is challenging and overall survival is poor." | 1.51 | Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden. ( Gbolahan, O; Hashemi-Sadraei, N; O'Neil, B, 2019) |
| "Data were analyzed from a prospective pancreatic cancer database." | 1.48 | Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy. ( Chabot, JA; Hecht, EM; Kluger, MD; Rashid, MF; Rosario, VL; Schrope, BA; Steinman, JA, 2018) |
| "Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%)." | 1.48 | Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy. ( Kanemitsu, Y; Ochiai, H; Shida, D; Tsukamoto, S, 2018) |
| "The presence of LNS in ypN0 rectal cancer patients after chemoradiotherapy should not be considered a factor for a poor prognosis." | 1.46 | Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer. ( Agostini, J; Benoist, S; Boige, V; Brouquet, A; Dartigues, P; Dumont, F; Goéré, D; Julié, C; Lazure, T; Penna, C; Peschaud, F; Vychnevskaia, K, 2017) |
| "A pathologic cervical residual tumor was observed in 16 patients (35." | 1.43 | [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy]. ( Ballester, M; Daraï, E; Huguet, F; Lauratet, B; Lefranc, JP; Monnier, L; Touboul, E, 2016) |
| "Nine days after CAF treatment, residual tumors showed features of regressive alterations and were composed of mesenchymal-like tumor cells, infiltrating immune cells and some tumor-associated fibroblasts with an intense deposition of collagen." | 1.42 | Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination. ( Alves, F; Deppert, W; Jannasch, K; Lenfert, E; Maenz, C; Wegwitz, F, 2015) |
| "A total of 377 patients with breast cancer who received preoperative chemotherapy were included in this retrospective study." | 1.42 | Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. ( Bago-Horvath, Z; Bartsch, R; Bergen, E; Dubsky, P; Exner, R; Gnant, M; Jakesz, R; Mittlböck, M; Ott, J; Panhofer, P; Promberger, R; Rudas, M; Seemann, R; Singer, C; Steger, G, 2015) |
| "Three and five years survival of gastric cancer patients subjected to adjuvant chemoradiotherapy was 53 and 41% respectively." | 1.40 | [Adjuvant chemoradiotherapy in advanced gastric cancer: experience in 168 patients]. ( Isa O, N; López V, H; Russo N, M, 2014) |
| "Esophageal obstruction prior to CCRT, residual tumor according to the first follow-up endoscopy, and poor follow-up computed tomography responses were significantly associated with locoregional failure." | 1.40 | Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation. ( Kim, HW; Kim, JH; Kim, JW; Lee, CG; Lee, IJ; Lee, YC; Park, H; Park, JJ; Youn, YH, 2014) |
| "Twenty-five patients with T3/T4N0 or N+ rectal cancer were enrolled." | 1.39 | Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. ( Broggi, S; Calandrino, R; De Cobelli, F; De Nardi, P; Di Muzio, N; Di Palo, S; Fiorino, C; Iacovelli, NA; Losio, C; Orsenigo, E; Passoni, P; Ricci, V; Ronzoni, M; Slim, N; Staudacher, C; Tamburini, A, 2013) |
| "Patients with small residual tumors (≤3 cm) radiologically staged ycT0-2N0 were treated by transanal endoscopic microsurgery." | 1.39 | Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. ( Bianchi, R; Gama-Rodrigues, J; Habr-Gama, A; Lynn, PB; Perez, RO; Proscurshim, I; São Julião, GP, 2013) |
| "A mucinous carcinoma was found in 21 of 88 patients." | 1.38 | Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. ( Düber, C; Hansen, T; Heintz, A; Hötker, AM; Junginger, T; Kreft, A; Kreitner, KF; Menig, M; Oberholzer, K; Schmidberger, H; Schneider, A, 2012) |
| "We obtained total RNA from residual cancer cells using microdissection from a total of 52 rectal cancer specimens from patients who underwent preoperative CRT." | 1.38 | Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy. ( Fujikawa, H; Inoue, Y; Kusunoki, M; Matsushita, K; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Uchida, K, 2012) |
| "In 10-24% of patients with rectal cancer who are treated with neoadjuvant chemoradiation, no residual tumor is found after surgery (ypT0)." | 1.37 | Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. ( Bakers, FC; Barbaro, B; Beets, GL; Beets-Tan, RG; Haustermans, K; Lambrecht, M; Lambregts, DM; Maas, M; Valentini, V; Vandecaveye, V, 2011) |
| "One hundred and fourteen cases of breast cancer with NA therapy were analyzed and clinical data were collected from March 2007 to December 2010." | 1.37 | [Primary systemic therapy in breast cancer patients (2007-2010)]. ( Farkas, R; Horváth, OP; Kálmán, E; Kovács, G; Kövér, E; Pavlovics, G; Szalai, G; Tizedes, G; Zapf, I, 2011) |
| "Thirty-three patients with rectal cancer underwent preoperative CRT." | 1.35 | Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. ( Ioue, Y; Kusunoki, M; Miki, C; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Yokoe, T, 2009) |
| "Five patients had less than one-third residual tumor cells in resected specimens histopathologically; eight had more than two-thirds residual tumor cells." | 1.35 | Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer. ( Kusunoki, M; Miki, C; Mohri, Y; Ohi, M; Otake, K; Tanaka, K; Toiyama, Y; Tonouchi, H; Yokoe, T, 2009) |
| "The incidence of gallbladder cancer (GBC) in the US is 1." | 1.35 | Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). ( Abou-Alfa, GK; Blumgart, LH; Capanu, M; D'Angelica, M; Dematteo, RP; Duffy, A; Fong, Y; Huitzil, D; Jarnagin, W; O'Reilly, EM, 2008) |
| "Fifty patients with advanced squamous cell carcinoma of the head and neck (SSCHN) who underwent MRI volumetry before and after neoadjuvant chemotherapy consisting of docetaxel, cisplatin, and 5-fluorouracil (TPF) were included in this study." | 1.34 | Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. ( Baghi, M; Bisdas, S; Gstoettner, W; Hambek, M; Knecht, R; Mack, MG; Muerthel, R; Vogl, T; Wagenblast, J, 2007) |
| "Delayed recurrences, common in breast cancer, are well explained by the concept of tumour dormancy." | 1.34 | Tumour dormancy in breast cancer: an update. ( Brackstone, M; Chambers, AF; Townson, JL, 2007) |
| "Complete response (no residual tumour, TRG 1) was seen in 7% of the patients (3/44) and total or major regression (TRG 1-3) in 73% of the patients (32/44) treated with 50-Gy chemoradiation." | 1.33 | Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma. ( Jantunen, I; Juhola, M; Kairaluoma, M; Kellokumpu, I; Vironen, J, 2005) |
| "Seventy-seven patients with primary breast cancer who had undergone neoadjuvant anthracycline-based chemotherapy were included in the present study." | 1.33 | Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. ( Alberti, S; Angelucci, D; Cianchetti, E; Ficorella, C; Iacobelli, S; Lattanzio, R; Marchetti, P; Natoli, C; Piantelli, M; Ricevuto, E; Tinari, N, 2006) |
| "Tegafur levels were also higher in tumor samples than other sites (mean 3446." | 1.33 | Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation. ( Aldaz, A; Alvarado, A; Arranz, JA; Calvo, FA; de la Mata, D; García, R; Giráldez, J; Serrano, J; Zufía, L, 2006) |
| "Diarrhea was the most frequent acute toxicity." | 1.31 | Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. ( Hagihara, PF; John, WJ; Kenady, DE; Marks, G; McGrath, PC; Mohiuddin, M; Regine, WF, 2000) |
| "For locally advanced primary colorectal cancer, our institution has combined intraoperative electron irradiation (IOERT) with external beam irradiation (EBRT) +/- 5-fluorouracil (5-FU) and surgical resection." | 1.30 | Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. ( Cha, S; Devine, R; Dozois, R; Fieck, JM; Gunderson, LL; Haddock, M; Martenson, JA; Nelson, H; O'Connell, MJ; Wolff, B, 1997) |
| "5-Fluorouracil was administered at an initial daily dose of 125 mg/m2, with dose escalation planned in 25-mg increments, depending on patient tolerance." | 1.30 | Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer. ( Burch, PA; Garton, GR; Kugler, JW; Martenson, JA; Pitot, HC; Santala, RG; Schroeder, G; Stella, PJ; Swaminathan, R; Wright, K, 1997) |
| "Thirteen (23%) of 56 women had no residual tumor." | 1.29 | Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. ( Adler, DD; Cody, RL; Helvie, MA; Joynt, LK; Merajver, SD; Pierce, LJ, 1996) |
| " Our preliminary data indicate that postradiation adjuvant chemotherapy with a weekly FP regimen at our dosage is not recommended for high-risk NPC." | 1.29 | Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma. ( Hsu, CY; Jan, JS; Lin, JC, 1996) |
| "All specimens showed residual tumour in the mastectomy specimen or the regional lymph nodes." | 1.29 | Locally advanced breast cancer: is surgery warranted following chemotherapy? ( Eaton, M; Humeniuk, V; Kent, AL; Marshall, N, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 33 (21.57) | 18.2507 |
| 2000's | 49 (32.03) | 29.6817 |
| 2010's | 64 (41.83) | 24.3611 |
| 2020's | 7 (4.58) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, NP | 1 |
| Villalon, R | 1 |
| Hartmann, D | 1 |
| Rodriguez, PM | 1 |
| Aedo, S | 1 |
| Sahin, IH | 2 |
| Lin, Y | 1 |
| Yothers, G | 1 |
| Lucas, PC | 1 |
| Deming, D | 1 |
| George, TJ | 1 |
| Kopetz, S | 1 |
| Lieu, CH | 1 |
| Dasari, A | 1 |
| Manceau, G | 1 |
| Margot, N | 1 |
| Augustin, J | 1 |
| Bardier, A | 1 |
| Simon, JM | 1 |
| Bachet, JB | 1 |
| Spano, JP | 1 |
| Maingon, P | 1 |
| Vaillant, JC | 1 |
| Karoui, M | 1 |
| Akiyoshi, T | 1 |
| Toda, S | 1 |
| Tominaga, T | 1 |
| Oba, K | 1 |
| Tomizawa, K | 1 |
| Hanaoka, Y | 1 |
| Nagasaki, T | 1 |
| Konishi, T | 1 |
| Matoba, S | 1 |
| Fukunaga, Y | 1 |
| Ueno, M | 1 |
| Kuroyanagi, H | 1 |
| Pederson, H | 1 |
| Staples, CJ | 1 |
| Housewright, C | 1 |
| von der Lippe Gythfeldt, H | 1 |
| Lien, T | 1 |
| Tekpli, X | 1 |
| Silwal-Pandit, L | 1 |
| Borgen, E | 1 |
| Garred, Ø | 1 |
| Skjerven, H | 1 |
| Schlichting, E | 1 |
| Lundgren, S | 1 |
| Wist, E | 1 |
| Naume, B | 1 |
| Kristensen, V | 1 |
| Børresen-Dale, AL | 1 |
| Lingjaerde, OC | 1 |
| Engebraaten, O | 1 |
| Barrak, D | 1 |
| Desale, S | 1 |
| Yoon, JJ | 1 |
| Dugan, MM | 1 |
| Kodavanti, PP | 1 |
| Sampah, ME | 1 |
| Sugarbaker, PH | 2 |
| Bigness, A | 1 |
| Imanirad, I | 1 |
| Xie, H | 1 |
| Frakes, J | 1 |
| Hoffe, S | 1 |
| Laskowitz, D | 1 |
| Felder, S | 1 |
| Epelboym, I | 1 |
| Zenati, MS | 1 |
| Hamad, A | 1 |
| Steve, J | 1 |
| Lee, KK | 1 |
| Bahary, N | 1 |
| Hogg, ME | 1 |
| Zeh, HJ | 1 |
| Zureikat, AH | 1 |
| Tsang, JS | 1 |
| Tong, DKH | 1 |
| Lam, KO | 1 |
| Law, BTT | 1 |
| Wong, IYH | 1 |
| Chan, DKK | 1 |
| Chan, FSY | 1 |
| Kwong, D | 1 |
| Law, S | 1 |
| Kluger, MD | 1 |
| Rashid, MF | 1 |
| Rosario, VL | 1 |
| Schrope, BA | 1 |
| Steinman, JA | 1 |
| Hecht, EM | 1 |
| Chabot, JA | 1 |
| Berriochoa, CA | 1 |
| Abdel-Wahab, M | 1 |
| Leyrer, CM | 1 |
| Khorana, A | 1 |
| Matthew Walsh, R | 1 |
| Kumar, AMS | 1 |
| Shida, D | 1 |
| Tsukamoto, S | 1 |
| Ochiai, H | 1 |
| Kanemitsu, Y | 1 |
| Fokas, E | 1 |
| Ströbel, P | 1 |
| Fietkau, R | 1 |
| Ghadimi, M | 1 |
| Liersch, T | 1 |
| Grabenbauer, GG | 1 |
| Hartmann, A | 1 |
| Kaufmann, M | 1 |
| Sauer, R | 1 |
| Graeven, U | 1 |
| Hoffmanns, H | 1 |
| Raab, HR | 1 |
| Hothorn, T | 1 |
| Wittekind, C | 1 |
| Rödel, C | 1 |
| Takemoto, K | 1 |
| Miyahara, N | 1 |
| Chikuie, N | 1 |
| Hamamoto, T | 1 |
| Ishino, T | 1 |
| Ueda, T | 1 |
| Takeno, S | 1 |
| Chow, OS | 1 |
| Patil, S | 1 |
| Keskin, M | 1 |
| Smith, JJ | 1 |
| Widmar, M | 1 |
| Smith, DD | 1 |
| Avila, K | 1 |
| Shia, J | 1 |
| Chu, P | 1 |
| Garcia-Aguilar, J | 1 |
| Li, Z | 1 |
| Xiao, D | 1 |
| Li, X | 1 |
| Zhan, P | 1 |
| Wang, J | 2 |
| Zhang, H | 1 |
| Yoon, G | 1 |
| Park, JY | 1 |
| Kim, HJ | 1 |
| Choi, GS | 1 |
| Kim, JG | 1 |
| Kang, BW | 1 |
| Kang, MK | 1 |
| Seo, AN | 1 |
| Oguma, J | 1 |
| Ozawa, S | 1 |
| Koyanagi, K | 1 |
| Kazuno, A | 1 |
| Yamamoto, M | 1 |
| Ninomiya, Y | 1 |
| Yatabe, K | 1 |
| Gbolahan, O | 1 |
| Hashemi-Sadraei, N | 1 |
| O'Neil, B | 1 |
| Passoni, P | 1 |
| Fiorino, C | 1 |
| Slim, N | 1 |
| Ronzoni, M | 1 |
| Ricci, V | 1 |
| Di Palo, S | 1 |
| De Nardi, P | 1 |
| Orsenigo, E | 1 |
| Tamburini, A | 1 |
| De Cobelli, F | 1 |
| Losio, C | 1 |
| Iacovelli, NA | 1 |
| Broggi, S | 1 |
| Staudacher, C | 1 |
| Calandrino, R | 1 |
| Di Muzio, N | 1 |
| Hequet, D | 1 |
| Marchand, E | 1 |
| Place, V | 1 |
| Fourchotte, V | 1 |
| De La Rochefordière, A | 1 |
| Dridi, S | 1 |
| Coutant, C | 1 |
| Lecuru, F | 1 |
| Bats, AS | 1 |
| Koskas, M | 1 |
| Bretel, JJ | 1 |
| Bricou, A | 1 |
| Delpech, Y | 1 |
| Barranger, E | 1 |
| Shimada, H | 1 |
| Nagata, M | 1 |
| Cho, A | 1 |
| Takiguchi, N | 1 |
| Kainuma, O | 1 |
| Soda, H | 1 |
| Ikeda, A | 1 |
| Nabeya, Y | 1 |
| Yajima, S | 1 |
| Yamamoto, H | 2 |
| Sugiyama, T | 1 |
| Itami, M | 1 |
| Kim, GJ | 1 |
| Koshy, M | 1 |
| Hanlon, AL | 1 |
| Horiba, MN | 1 |
| Edelman, MJ | 1 |
| Burrows, WM | 1 |
| Battafarano, RJ | 1 |
| Suntharalingam, M | 1 |
| Myerson, RJ | 1 |
| Tan, B | 1 |
| Hunt, S | 1 |
| Olsen, J | 1 |
| Birnbaum, E | 1 |
| Fleshman, J | 1 |
| Gao, F | 1 |
| Hall, L | 1 |
| Kodner, I | 1 |
| Lockhart, AC | 1 |
| Mutch, M | 1 |
| Naughton, M | 1 |
| Picus, J | 1 |
| Rigden, C | 1 |
| Safar, B | 1 |
| Sorscher, S | 1 |
| Suresh, R | 1 |
| Wang-Gillam, A | 1 |
| Parikh, P | 1 |
| Isa O, N | 1 |
| Russo N, M | 1 |
| López V, H | 1 |
| Swellengrebel, HA | 1 |
| Bosch, SL | 1 |
| Cats, A | 1 |
| Vincent, AD | 1 |
| Dewit, LG | 1 |
| Verwaal, VJ | 2 |
| Nagtegaal, ID | 1 |
| Marijnen, CA | 1 |
| Park, HJ | 1 |
| Kim, K | 2 |
| Chie, EK | 2 |
| Jang, JY | 2 |
| Kim, SW | 2 |
| Han, SW | 2 |
| Oh, DY | 2 |
| Im, SA | 2 |
| Kim, TY | 2 |
| Bang, YJ | 2 |
| Ha, SW | 2 |
| Jannasch, K | 1 |
| Wegwitz, F | 1 |
| Lenfert, E | 1 |
| Maenz, C | 1 |
| Deppert, W | 1 |
| Alves, F | 1 |
| Kim, HW | 1 |
| Kim, JH | 3 |
| Lee, IJ | 1 |
| Kim, JW | 1 |
| Lee, YC | 1 |
| Lee, CG | 1 |
| Park, JJ | 1 |
| Youn, YH | 1 |
| Park, H | 1 |
| Mombelli, S | 1 |
| Kwiatkowski, F | 1 |
| Abrial, C | 1 |
| Wang-Lopez, Q | 1 |
| de Boissieu, P | 1 |
| Garbar, C | 1 |
| Bensussan, A | 1 |
| Curé, H | 1 |
| Malik, H | 1 |
| Khan, AZ | 1 |
| Berry, DP | 1 |
| Cameron, IC | 1 |
| Pope, I | 1 |
| Sherlock, D | 1 |
| Helmy, S | 1 |
| Byrne, B | 1 |
| Thompson, M | 1 |
| Pulfer, A | 1 |
| Davidson, B | 1 |
| Ghosn, M | 1 |
| Kourie, HR | 1 |
| Abdayem, P | 1 |
| Antoun, J | 1 |
| Nasr, D | 1 |
| Yokota, T | 1 |
| Ando, N | 1 |
| Igaki, H | 1 |
| Shinoda, M | 1 |
| Kato, K | 1 |
| Mizusawa, J | 1 |
| Katayama, H | 1 |
| Nakamura, K | 1 |
| Fukuda, H | 1 |
| Kitagawa, Y | 1 |
| Peintinger, F | 2 |
| Sinn, B | 2 |
| Hatzis, C | 3 |
| Albarracin, C | 1 |
| Downs-Kelly, E | 1 |
| Morkowski, J | 1 |
| Gould, R | 2 |
| Symmans, WF | 5 |
| Chiu, CH | 1 |
| Chen, WH | 1 |
| Wen, YW | 1 |
| Yeh, CJ | 1 |
| Chao, YK | 1 |
| Chang, HK | 1 |
| Tseng, CK | 1 |
| Liu, YH | 1 |
| Promberger, R | 1 |
| Dubsky, P | 1 |
| Mittlböck, M | 1 |
| Ott, J | 1 |
| Singer, C | 1 |
| Seemann, R | 1 |
| Exner, R | 1 |
| Panhofer, P | 1 |
| Steger, G | 1 |
| Bergen, E | 1 |
| Gnant, M | 1 |
| Jakesz, R | 1 |
| Bago-Horvath, Z | 1 |
| Rudas, M | 1 |
| Bartsch, R | 1 |
| Rupinski, M | 1 |
| Szczepkowski, M | 1 |
| Malinowska, M | 1 |
| Mroz, A | 1 |
| Pietrzak, L | 1 |
| Wyrwicz, L | 1 |
| Rutkowski, A | 1 |
| Bujko, K | 2 |
| Monnier, L | 1 |
| Touboul, E | 1 |
| Daraï, E | 1 |
| Lefranc, JP | 1 |
| Lauratet, B | 1 |
| Ballester, M | 1 |
| Huguet, F | 1 |
| Ueki, T | 1 |
| Manabe, T | 1 |
| Inoue, S | 1 |
| Ienaga, J | 1 |
| Yamanaka, N | 1 |
| Egami, T | 1 |
| Ishikawa, M | 1 |
| Konomi, H | 1 |
| Ikubo, A | 1 |
| Nagayoshi, K | 1 |
| Nakamura, M | 1 |
| Tanaka, M | 1 |
| Dai, Y | 1 |
| Wang, L | 1 |
| Tang, J | 1 |
| Cao, P | 1 |
| Luo, Z | 1 |
| Sun, J | 1 |
| Kiflu, A | 1 |
| Sai, B | 1 |
| Zhang, M | 1 |
| Wang, F | 1 |
| Li, G | 1 |
| Xiang, J | 1 |
| Katz, MH | 1 |
| Shi, Q | 1 |
| Ahmad, SA | 1 |
| Herman, JM | 1 |
| Marsh, Rde W | 1 |
| Collisson, E | 1 |
| Schwartz, L | 1 |
| Frankel, W | 1 |
| Martin, R | 1 |
| Conway, W | 1 |
| Truty, M | 1 |
| Kindler, H | 1 |
| Lowy, AM | 1 |
| Bekaii-Saab, T | 1 |
| Philip, P | 1 |
| Talamonti, M | 1 |
| Cardin, D | 1 |
| LoConte, N | 1 |
| Shen, P | 1 |
| Hoffman, JP | 1 |
| Venook, AP | 1 |
| Ma, Y | 1 |
| Zhang, S | 1 |
| Zang, L | 1 |
| Li, J | 2 |
| Kang, Y | 1 |
| Ren, W | 1 |
| Ihemelandu, C | 1 |
| Vychnevskaia, K | 1 |
| Dumont, F | 1 |
| Agostini, J | 1 |
| Julié, C | 1 |
| Dartigues, P | 1 |
| Lazure, T | 1 |
| Boige, V | 2 |
| Goéré, D | 1 |
| Brouquet, A | 1 |
| Penna, C | 1 |
| Peschaud, F | 1 |
| Benoist, S | 1 |
| Wei, C | 1 |
| Yu, X | 1 |
| Zhang, Y | 1 |
| Liu, M | 1 |
| Walls, A | 1 |
| Bousamra, A | 1 |
| Ramineni, M | 1 |
| Hunt, K | 2 |
| Buchholz, TA | 1 |
| Valero, V | 2 |
| Buzdar, AU | 7 |
| Yang, W | 1 |
| Brewster, AM | 1 |
| Moulder, S | 1 |
| Pusztai, L | 4 |
| Hortobagyi, GN | 4 |
| Higuchi, I | 1 |
| Yasuda, T | 3 |
| Yano, M | 1 |
| Doki, Y | 1 |
| Miyata, H | 1 |
| Tatsumi, M | 1 |
| Fukunaga, H | 1 |
| Takiguchi, S | 1 |
| Fujiwara, Y | 1 |
| Hatazawa, J | 1 |
| Monden, M | 1 |
| Kuerer, HM | 2 |
| Mejia, JA | 2 |
| Gonzalez-Angulo, AM | 1 |
| Esteva, FJ | 2 |
| Dawood, SS | 1 |
| Green, MC | 1 |
| Rosenthal, DI | 1 |
| Catalano, PJ | 1 |
| Haller, DG | 1 |
| Landry, JC | 1 |
| Sigurdson, ER | 1 |
| Spitz, FR | 2 |
| Benson, AB | 1 |
| Duffy, A | 1 |
| Capanu, M | 1 |
| Abou-Alfa, GK | 1 |
| Huitzil, D | 1 |
| Jarnagin, W | 1 |
| Fong, Y | 1 |
| D'Angelica, M | 1 |
| Dematteo, RP | 1 |
| Blumgart, LH | 1 |
| O'Reilly, EM | 1 |
| Kim, MK | 1 |
| Cho, KJ | 1 |
| Park, SI | 1 |
| Kim, YH | 1 |
| Song, HY | 1 |
| Shin, JH | 1 |
| Jung, HY | 1 |
| Lee, GH | 1 |
| Choi, KD | 1 |
| Song, HJ | 1 |
| Ryu, JS | 1 |
| Kim, SB | 1 |
| Daliani, DD | 1 |
| Tannir, NM | 1 |
| Papandreou, CN | 1 |
| Wang, X | 1 |
| Swisher, S | 1 |
| Wood, CG | 1 |
| Swanson, DA | 1 |
| Logothetis, CJ | 1 |
| Jonasch, E | 1 |
| Tanaka, K | 3 |
| Otake, K | 1 |
| Mohri, Y | 1 |
| Ohi, M | 1 |
| Yokoe, T | 2 |
| Toiyama, Y | 3 |
| Miki, C | 2 |
| Tonouchi, H | 1 |
| Kusunoki, M | 3 |
| Kersting, S | 1 |
| Konopke, R | 1 |
| Dittert, D | 1 |
| Distler, M | 1 |
| Rückert, F | 1 |
| Gastmeier, J | 1 |
| Baretton, GB | 1 |
| Saeger, HD | 1 |
| Saigusa, S | 2 |
| Okugawa, Y | 2 |
| Ioue, Y | 1 |
| Dose-Schwarz, J | 1 |
| Tiling, R | 1 |
| Avril-Sassen, S | 1 |
| Mahner, S | 1 |
| Lebeau, A | 1 |
| Weber, C | 1 |
| Schwaiger, M | 1 |
| Jänicke, F | 1 |
| Untch, M | 1 |
| Avril, N | 1 |
| Hillel, AT | 1 |
| Fakhry, C | 1 |
| Pai, SI | 1 |
| Williams, MF | 1 |
| Blanco, RG | 1 |
| Zinreich, ES | 1 |
| Levine, MA | 1 |
| Westra, WH | 1 |
| Saunders, JR | 1 |
| Ha, PK | 1 |
| Park, JH | 1 |
| Choi, EK | 1 |
| Ahn, SD | 2 |
| Lee, SW | 1 |
| Song, SY | 1 |
| Yoon, SM | 1 |
| Kim, YS | 1 |
| Lee, YS | 1 |
| Lee, SG | 1 |
| Hwang, S | 1 |
| Lee, YJ | 1 |
| Park, KM | 1 |
| Kim, TW | 1 |
| Chang, HM | 1 |
| Lee, JL | 1 |
| Lordick, F | 1 |
| Grenacher, L | 1 |
| Röcken, C | 1 |
| Ebert, M | 1 |
| Moehler, M | 1 |
| Schumacher, G | 1 |
| Li, SP | 1 |
| Taylor, NJ | 1 |
| Makris, A | 3 |
| Ah-See, ML | 2 |
| Beresford, MJ | 2 |
| Stirling, JJ | 1 |
| d'Arcy, JA | 1 |
| Collins, DJ | 1 |
| Padhani, AR | 1 |
| Oberholzer, K | 1 |
| Menig, M | 1 |
| Kreft, A | 1 |
| Schneider, A | 1 |
| Junginger, T | 1 |
| Heintz, A | 1 |
| Kreitner, KF | 1 |
| Hötker, AM | 1 |
| Hansen, T | 1 |
| Düber, C | 1 |
| Schmidberger, H | 1 |
| Clavel, S | 1 |
| Charron, MP | 1 |
| Bélair, M | 1 |
| Delouya, G | 1 |
| Fortin, B | 1 |
| Després, P | 1 |
| Soulières, D | 1 |
| Filion, E | 1 |
| Guertin, L | 1 |
| Nguyen-Tan, PF | 1 |
| Lambregts, DM | 1 |
| Vandecaveye, V | 1 |
| Barbaro, B | 1 |
| Bakers, FC | 1 |
| Lambrecht, M | 1 |
| Maas, M | 1 |
| Haustermans, K | 1 |
| Valentini, V | 1 |
| Beets, GL | 1 |
| Beets-Tan, RG | 1 |
| Giorda, G | 1 |
| Boz, G | 1 |
| Gadducci, A | 1 |
| Lucia, E | 1 |
| De Piero, G | 1 |
| De Paoli, A | 1 |
| Innocente, R | 1 |
| Trovò, M | 1 |
| Sorio, R | 1 |
| Campagnutta, E | 1 |
| Swisher, SG | 1 |
| Winter, KA | 1 |
| Komaki, RU | 1 |
| Ajani, JA | 1 |
| Wu, TT | 1 |
| Hofstetter, WL | 1 |
| Konski, AA | 1 |
| Willett, CG | 2 |
| Zambetti, M | 1 |
| Mansutti, M | 1 |
| Gomez, P | 1 |
| Lluch, A | 1 |
| Dittrich, C | 1 |
| Zamagni, C | 1 |
| Ciruelos, E | 1 |
| Pavesi, L | 1 |
| Semiglazov, V | 1 |
| De Benedictis, E | 1 |
| Gaion, F | 1 |
| Bari, M | 1 |
| Morandi, P | 1 |
| Valagussa, P | 1 |
| Luca, G | 1 |
| Dalton, RS | 1 |
| Velineni, R | 1 |
| Osborne, ME | 1 |
| Thomas, R | 1 |
| Harries, S | 1 |
| Gee, AS | 1 |
| Daniels, IR | 1 |
| Roy, P | 1 |
| Serra, S | 1 |
| Kennedy, E | 1 |
| Chetty, R | 1 |
| Zapf, I | 1 |
| Tizedes, G | 1 |
| Pavlovics, G | 1 |
| Kovács, G | 1 |
| Kálmán, E | 1 |
| Szalai, G | 1 |
| Kövér, E | 1 |
| Farkas, R | 1 |
| Horváth, OP | 1 |
| Fujikawa, H | 1 |
| Matsushita, K | 1 |
| Uchida, K | 1 |
| Inoue, Y | 1 |
| Soltys, SG | 1 |
| Choi, CY | 1 |
| Fee, WE | 1 |
| Pinto, HA | 1 |
| Le, QT | 1 |
| Seehaus, A | 1 |
| Vacaro, C | 1 |
| Ocantos, J | 1 |
| Varela, A | 1 |
| Savluk, L | 1 |
| Ojea Quintana, G | 1 |
| Rossi, G | 1 |
| Weimbaur, V | 1 |
| Pablo Santino, J | 1 |
| García-Mónaco, R | 1 |
| Ferrero, A | 1 |
| Langella, S | 1 |
| Russolillo, N | 1 |
| Vigano', L | 1 |
| Lo Tesoriere, R | 1 |
| Capussotti, L | 1 |
| Arvold, ND | 1 |
| Fernandez-del Castillo, C | 1 |
| Ryan, DP | 1 |
| Ferrone, CR | 1 |
| Clark, JW | 1 |
| Blaszkowsky, LS | 1 |
| Deshpande, V | 1 |
| Niemierko, A | 1 |
| Allen, JN | 1 |
| Kwak, EL | 1 |
| Wadlow, RC | 1 |
| Zhu, AX | 1 |
| Warshaw, AL | 1 |
| Hong, TS | 1 |
| Bentzen, AG | 1 |
| Guren, MG | 1 |
| Wanderås, EH | 1 |
| Frykholm, G | 1 |
| Tveit, KM | 1 |
| Wilsgaard, T | 1 |
| Dahl, O | 1 |
| Balteskard, L | 1 |
| Arrazubi, V | 1 |
| Suárez, J | 1 |
| Guerrero, D | 1 |
| Gómez, M | 1 |
| Viúdez, A | 1 |
| Arias, F | 1 |
| Balén, E | 1 |
| Vera, R | 1 |
| Waseda, Y | 1 |
| Komai, Y | 1 |
| Yano, A | 1 |
| Fujii, Y | 1 |
| Noguchi, N | 1 |
| Kihara, K | 1 |
| Perez, RO | 1 |
| Habr-Gama, A | 1 |
| Lynn, PB | 1 |
| São Julião, GP | 1 |
| Bianchi, R | 1 |
| Proscurshim, I | 1 |
| Gama-Rodrigues, J | 1 |
| Beriwal, S | 1 |
| Shukla, G | 1 |
| Shinde, A | 1 |
| Heron, DE | 1 |
| Kelley, JL | 1 |
| Edwards, RP | 1 |
| Sukumvanich, P | 1 |
| Richards, S | 1 |
| Olawaiye, AB | 1 |
| Krivak, TC | 1 |
| Zanoni, A | 1 |
| Verlato, G | 1 |
| Giacopuzzi, S | 1 |
| Weindelmayer, J | 1 |
| Casella, F | 1 |
| Pasini, F | 1 |
| Zhao, E | 1 |
| de Manzoni, G | 1 |
| Datta, NR | 1 |
| Nagar, YS | 1 |
| Singh, S | 1 |
| Naryan, L | 1 |
| Lin, JC | 2 |
| Jan, JS | 2 |
| Chen, KY | 1 |
| Hsu, CY | 2 |
| Liang, WM | 1 |
| Wang, WY | 1 |
| Nishimura, Y | 1 |
| Koike, R | 1 |
| Nakamatsu, K | 1 |
| Kanamori, S | 1 |
| Suzuki, M | 1 |
| Shigeoka, H | 1 |
| Shiozaki, H | 1 |
| Lim, JT | 1 |
| Truong, PT | 1 |
| Berthelet, E | 1 |
| Pai, H | 1 |
| Joe, H | 1 |
| Wai, E | 1 |
| Larsson, S | 1 |
| Kader, HA | 1 |
| Weinerman, B | 1 |
| Wilson, K | 1 |
| Olivotto, IA | 1 |
| Rajan, R | 1 |
| Poniecka, A | 1 |
| Smith, TL | 1 |
| Yang, Y | 1 |
| Frye, D | 1 |
| Fiterman, DJ | 1 |
| Gal-Gombos, E | 1 |
| Whitman, G | 1 |
| Rouzier, R | 1 |
| Green, M | 1 |
| Kuerer, H | 1 |
| Elias, D | 1 |
| Sideris, L | 1 |
| Pocard, M | 1 |
| Edè, C | 1 |
| Ben Hassouna, D | 1 |
| Ducreux, M | 1 |
| Côté, JF | 1 |
| Lasser, P | 1 |
| van Tinteren, H | 1 |
| van Ruth, S | 1 |
| Zoetmulder, FA | 1 |
| Bathe, OF | 1 |
| Dowden, S | 1 |
| Sutherland, F | 1 |
| Dixon, E | 1 |
| Butts, C | 1 |
| Bigam, D | 1 |
| Walley, B | 1 |
| Ruether, D | 1 |
| Ernst, S | 1 |
| Altundag, O | 1 |
| Gullu, I | 1 |
| Altundag, K | 2 |
| Yalcin, S | 1 |
| Ozyar, E | 1 |
| Cengiz, M | 1 |
| Akyol, F | 1 |
| Yucel, T | 1 |
| Hosal, S | 1 |
| Sozeri, B | 1 |
| Denis, F | 1 |
| Desbiez-Bourcier, AV | 1 |
| Chapiron, C | 1 |
| Arbion, F | 1 |
| Body, G | 1 |
| Brunereau, L | 1 |
| Klug, C | 1 |
| Wutzl, A | 1 |
| Kermer, C | 1 |
| Ploder, O | 1 |
| Sulzbacher, I | 1 |
| Selzer, E | 1 |
| Voracek, M | 1 |
| Oeckher, M | 1 |
| Ewers, R | 1 |
| Millesi, W | 1 |
| Vironen, J | 1 |
| Juhola, M | 1 |
| Kairaluoma, M | 1 |
| Jantunen, I | 1 |
| Kellokumpu, I | 1 |
| Warnecke-Eberz, U | 1 |
| Hokita, S | 1 |
| Xi, H | 1 |
| Higashi, H | 2 |
| Baldus, SE | 1 |
| Metzger, R | 1 |
| Brabender, J | 1 |
| Bollschweiler, E | 1 |
| Mueller, RP | 1 |
| Dienes, HP | 1 |
| Hoelscher, AH | 1 |
| Schneider, PM | 1 |
| O'Connor, JK | 1 |
| Sause, WT | 1 |
| Hazard, LJ | 1 |
| Belnap, LP | 1 |
| Noyes, RD | 1 |
| Mawdsley, S | 1 |
| Glynne-Jones, R | 1 |
| Grainger, J | 1 |
| Richman, P | 1 |
| Harrison, M | 1 |
| Ashford, R | 1 |
| Harrison, RA | 1 |
| Osborne, M | 1 |
| Livingstone, JI | 1 |
| MacDonald, P | 1 |
| Mitchell, IC | 1 |
| Meyrick-Thomas, J | 1 |
| Northover, JM | 1 |
| Windsor, A | 1 |
| Novell, R | 1 |
| Wallace, M | 1 |
| Douek, M | 1 |
| Tobias, J | 1 |
| Ambrosini-Spaltro, A | 1 |
| Salvi, F | 1 |
| Betts, CM | 1 |
| Frezza, GP | 1 |
| Piemontese, A | 1 |
| Del Prete, P | 1 |
| Baldoni, C | 1 |
| Foschini, MP | 1 |
| Viale, G | 1 |
| Chagpar, AB | 1 |
| Middleton, LP | 1 |
| Sahin, AA | 1 |
| Dempsey, P | 1 |
| Mirza, AN | 1 |
| Ames, FC | 2 |
| Babiera, GV | 1 |
| Feig, BW | 2 |
| Hunt, KK | 2 |
| Meric-Bernstam, F | 1 |
| Ross, MI | 2 |
| Singletary, SE | 3 |
| Chmielik, E | 1 |
| Nasierowska-Guttmejer, A | 1 |
| Nowacki, MP | 1 |
| Kepka, L | 1 |
| Sopylo, R | 1 |
| Wojnar, A | 1 |
| Majewski, P | 1 |
| Sygut, J | 1 |
| Karmolinski, A | 1 |
| Huzarski, T | 1 |
| Wandzel, P | 1 |
| Tinari, N | 1 |
| Lattanzio, R | 1 |
| Natoli, C | 1 |
| Cianchetti, E | 1 |
| Angelucci, D | 1 |
| Ricevuto, E | 1 |
| Ficorella, C | 1 |
| Marchetti, P | 1 |
| Alberti, S | 1 |
| Piantelli, M | 1 |
| Iacobelli, S | 1 |
| Lee, MJ | 1 |
| Ra, YS | 1 |
| Park, JB | 1 |
| Goo, HW | 1 |
| Khang, SK | 1 |
| Song, JS | 1 |
| Kim, YJ | 1 |
| Ghim, TT | 1 |
| Calvo, FA | 1 |
| Aldaz, A | 1 |
| Zufía, L | 1 |
| de la Mata, D | 1 |
| Serrano, J | 1 |
| García, R | 1 |
| Arranz, JA | 1 |
| Alvarado, A | 1 |
| Giráldez, J | 1 |
| Burcombe, R | 1 |
| Stott, D | 1 |
| Dequanter, D | 1 |
| Lothaire, P | 1 |
| Awada, A | 1 |
| Lalami, Y | 1 |
| Hien Nguyen, T | 1 |
| Lemort, M | 1 |
| Vandevelde, L | 1 |
| Andry, G | 1 |
| Baghi, M | 1 |
| Mack, MG | 1 |
| Hambek, M | 1 |
| Bisdas, S | 1 |
| Muerthel, R | 1 |
| Wagenblast, J | 1 |
| Gstoettner, W | 1 |
| Vogl, T | 1 |
| Knecht, R | 1 |
| Yang, JJ | 1 |
| Xiang, Y | 1 |
| Wan, XR | 1 |
| Li, JG | 1 |
| Yang, XY | 1 |
| Brackstone, M | 1 |
| Townson, JL | 1 |
| Chambers, AF | 1 |
| Lin, D | 1 |
| Glastonbury, CM | 1 |
| Rafaelian, O | 1 |
| Eisele, DW | 1 |
| Wang, SJ | 1 |
| Lin, F | 1 |
| Yan, K | 1 |
| Austin, JR | 1 |
| Wong, FC | 1 |
| Kim, EE | 1 |
| Tsuji, Y | 3 |
| Nishimura, A | 2 |
| Katsuki, Y | 3 |
| Rice, TW | 2 |
| Adelstein, DJ | 2 |
| Koka, A | 1 |
| Tefft, M | 1 |
| Kirby, TJ | 1 |
| Van Kirk, MA | 1 |
| Taylor, ME | 1 |
| Olencki, TE | 1 |
| Peereboom, D | 1 |
| Budd, GT | 1 |
| Kent, AL | 1 |
| Eaton, M | 1 |
| Marshall, N | 1 |
| Humeniuk, V | 1 |
| Girvin, GW | 1 |
| Matsumoto, GH | 1 |
| Bates, DM | 1 |
| Garcia, JM | 1 |
| Clyde, JC | 1 |
| Lin, PH | 1 |
| Ito, H | 1 |
| Ogawa, T | 1 |
| Murayama, M | 1 |
| Fujino, K | 1 |
| Horii, H | 1 |
| Imai, J | 1 |
| Kobayashi, H | 1 |
| Yamada, S | 1 |
| Watanabe, C | 1 |
| Ishiyama, M | 1 |
| Furukawa, Y | 1 |
| Otani, Y | 2 |
| Ihara, A | 1 |
| Tsuji, R | 1 |
| Okamura, R | 1 |
| Sato, K | 1 |
| Hiki, Y | 1 |
| Matsumoto, M | 1 |
| Machida, T | 1 |
| Kitazaki, M | 1 |
| Ishihara, S | 1 |
| Noma, M | 1 |
| Ota, M | 1 |
| Ban, K | 1 |
| Masuda, K | 1 |
| Shida, H | 1 |
| Braly, PS | 1 |
| Berek, JS | 1 |
| Blessing, JA | 1 |
| Homesley, HD | 1 |
| Averette, H | 1 |
| Hoshino, M | 1 |
| Koyama, Y | 1 |
| Igarashi, W | 1 |
| Ohtake, T | 1 |
| Ono, T | 1 |
| Sato, N | 1 |
| Hatakeyama, Y | 1 |
| Abe, R | 1 |
| Tono, T | 1 |
| Tamaki, Y | 1 |
| Yagyu, T | 2 |
| Mishima, H | 2 |
| Nakagawa, H | 1 |
| Cho, G | 1 |
| Shin, E | 2 |
| Kobayashi, K | 2 |
| Takatsuka, Y | 1 |
| Kikkawa, N | 2 |
| Takahashi, K | 1 |
| Mori, T | 1 |
| Takahashi, T | 2 |
| Takano, S | 1 |
| Moriguchi, M | 1 |
| Seki, N | 1 |
| Higaki, T | 1 |
| Watanabe, Y | 1 |
| Ito, Y | 1 |
| Oishi, H | 1 |
| Nakata, Y | 1 |
| Kono, S | 1 |
| Bates, BA | 1 |
| Detterbeck, FC | 1 |
| Bernard, SA | 1 |
| Qaqish, BF | 1 |
| Tepper, JE | 1 |
| Helvie, MA | 1 |
| Joynt, LK | 1 |
| Cody, RL | 1 |
| Pierce, LJ | 1 |
| Adler, DD | 1 |
| Merajver, SD | 1 |
| Zinzani, PL | 1 |
| Zompatori, M | 1 |
| Bendandi, M | 1 |
| Battista, G | 1 |
| Fanti, S | 1 |
| Barbieri, E | 1 |
| Gherlinzoni, F | 1 |
| Rimondi, MR | 1 |
| Frezza, G | 1 |
| Pisi, P | 1 |
| Merla, E | 1 |
| Gozzetti, A | 1 |
| Canini, R | 1 |
| Monetti, N | 1 |
| Babini, L | 1 |
| Tura, S | 1 |
| Flam, M | 1 |
| John, M | 1 |
| Pajak, TF | 1 |
| Petrelli, N | 1 |
| Myerson, R | 1 |
| Doggett, S | 1 |
| Quivey, J | 1 |
| Rotman, M | 1 |
| Kerman, H | 1 |
| Coia, L | 1 |
| Murray, K | 1 |
| Yanagi, I | 1 |
| Koga, A | 1 |
| Okuda, K | 1 |
| Nishio, T | 1 |
| Shibata, J | 1 |
| Aso, K | 1 |
| Matuo, H | 1 |
| Nagashima, J | 1 |
| So, H | 1 |
| Nakayama, T | 1 |
| Hasuike, Y | 1 |
| Fukuda, K | 1 |
| Kobayashi, T | 1 |
| Gunderson, LL | 2 |
| Nelson, H | 1 |
| Martenson, JA | 2 |
| Cha, S | 1 |
| Haddock, M | 1 |
| Devine, R | 1 |
| Fieck, JM | 1 |
| Wolff, B | 1 |
| Dozois, R | 1 |
| O'Connell, MJ | 1 |
| Swaminathan, R | 1 |
| Burch, PA | 1 |
| Santala, RG | 1 |
| Schroeder, G | 1 |
| Pitot, HC | 1 |
| Wright, K | 1 |
| Kugler, JW | 1 |
| Stella, PJ | 1 |
| Garton, GR | 1 |
| Kling, KM | 1 |
| Ostrzega, N | 1 |
| Schmit, P | 1 |
| Matsumoto, N | 1 |
| Umekita, N | 1 |
| Maeshiro, T | 1 |
| Miyamoto, S | 1 |
| Awane, Y | 1 |
| Miki, H | 1 |
| Shibata, N | 1 |
| Noguchi, S | 1 |
| Tamai, M | 1 |
| Hamada, H | 1 |
| Hashimoto, M | 1 |
| Kujime, J | 1 |
| Yamagami, H | 1 |
| Tomita, I | 1 |
| Kimura, J | 1 |
| Ohira, S | 1 |
| Giacco, GG | 1 |
| Hess, K | 1 |
| Larry, L | 1 |
| Rich, TA | 2 |
| Janjan, N | 1 |
| Cleary, KR | 2 |
| Skibber, JM | 1 |
| Zuccaro, G | 1 |
| Goldblum, J | 1 |
| Medendorp, SV | 1 |
| Becker, M | 1 |
| Pimentel, R | 1 |
| Gitlin, L | 1 |
| Janjan, NA | 1 |
| Khoo, VS | 1 |
| Abbruzzese, J | 1 |
| Pazdur, R | 1 |
| Dubrow, R | 1 |
| Allen, PK | 2 |
| Lynch, PM | 1 |
| Glober, G | 1 |
| Wolff, R | 1 |
| Skibber, J | 1 |
| Takanishi, K | 1 |
| Matsumoto, J | 1 |
| Minami, T | 1 |
| Carr, JA | 1 |
| Ajlouni, M | 1 |
| Wollner, I | 1 |
| Wong, D | 1 |
| Velanovich, V | 1 |
| Mohiuddin, M | 2 |
| Regine, WF | 2 |
| John, WJ | 1 |
| Hagihara, PF | 2 |
| McGrath, PC | 1 |
| Kenady, DE | 1 |
| Marks, G | 1 |
| Vlastos, G | 1 |
| Mirza, NQ | 1 |
| Lenert, JT | 1 |
| Liao, Z | 1 |
| Strom, EA | 1 |
| McNeese, MD | 1 |
| Hayne, M | 1 |
| Hanna, N | 1 |
| McGrath, P | 1 |
| Marks, GM | 1 |
| Mehta, VK | 1 |
| Fisher, GA | 1 |
| Ford, JM | 1 |
| Oberhelman, HA | 1 |
| Vierra, MA | 1 |
| Bastidas, AJ | 1 |
| Poen, JC | 1 |
| Brown, RS | 1 |
| McCormack, M | 1 |
| Lankester, KJ | 1 |
| Spittle, MF | 1 |
| Witte, RS | 1 |
| Cnaan, A | 1 |
| Mansour, EG | 1 |
| Barylak, E | 1 |
| Harris, JE | 1 |
| Schutt, AJ | 1 |
| Dunne, B | 1 |
| Reynolds, JV | 1 |
| Mulligan, E | 1 |
| Kelly, A | 1 |
| Griffin, M | 1 |
| Onaitis, MW | 1 |
| Noone, RB | 1 |
| Fields, R | 1 |
| Hurwitz, H | 1 |
| Morse, M | 1 |
| Jowell, P | 1 |
| McGrath, K | 1 |
| Lee, C | 1 |
| Anscher, MS | 1 |
| Clary, B | 1 |
| Mantyh, C | 1 |
| Pappas, TN | 1 |
| Ludwig, K | 1 |
| Seigler, HF | 1 |
| Tyler, DS | 1 |
| Kresl, JJ | 1 |
| Schild, SE | 1 |
| Henning, GT | 1 |
| Donohue, J | 1 |
| Pitot, H | 1 |
| Haddock, MG | 1 |
| Nagorney, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Trial of the Efficacy of Adjuvant Chemotherapy in Patients With Residual Lesions After Concurrent Radiochemotherapy for Locally Advanced Cervical Cancer[NCT04409860] | 120 participants (Anticipated) | Interventional | 2020-05-26 | Recruiting | |||
| A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice[NCT01460745] | 60 participants (Actual) | Observational | 2011-11-30 | Completed | |||
| Neoadjuvant FOLFIRINOX and Chemoradiation Followed by Definitive Surgery and Postoperative Gemcitabine for Patients With Borderline Resectable Pancreatic Adenocarcinoma: An Intergroup Single-Arm Pilot Study[NCT01821612] | Early Phase 1 | 23 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| A Study of Preoperative FOLFIRINOX For Potentially Curable Pancreatic Cancer[NCT03167112] | Phase 2 | 20 participants (Anticipated) | Interventional | 2017-07-03 | Recruiting | ||
| Follow up and Functional Outcome of Organ Saving Treatment in Patients With Good Response to Neo-adjuvant (Chemo)Radiation for Rectal Cancer[NCT02278653] | 100 participants (Anticipated) | Observational [Patient Registry] | 2014-03-31 | Active, not recruiting | |||
| Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer[NCT01721785] | 307 participants (Actual) | Observational | 2012-10-31 | Completed | |||
| A Phase II Study Of Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus[NCT00069953] | Phase 2 | 43 participants (Actual) | Interventional | 2003-09-30 | Completed | ||
| "Radical External Beam Chemoradiation in Patients With Rectal Cancer: a Wait-and-see Approach"[NCT03001362] | 48 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | |||
| A Phase III Clinical Trial of Docetaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma[NCT02465736] | Phase 3 | 610 participants (Anticipated) | Interventional | 2015-07-31 | Recruiting | ||
| Long-term Results of Plasma Epstein-Barr Virus DNA Monitoring In Nasopharyngeal Carcinoma After Curative Treatment[NCT03973723] | 441 participants (Actual) | Observational | 2011-08-01 | Completed | |||
| Prospective Clinical Trial to Assess a Mini-invasive Pre-surgical Procedure to Detect Residual Breast or Axillary Disease in Patients With cT1-T2-T3 cN0/N1 Breast Cancer in Complete Clinical/Radiological Remission After Primary Chemotherapy[NCT05951699] | 105 participants (Anticipated) | Observational | 2022-04-28 | Recruiting | |||
| Early Assessment of Shear Wave Elastography Parameters to Assess the Response to Neoadjuvant Chemotherapy in Patients With Invasive Breast Cancer[NCT05068999] | 35 participants (Anticipated) | Observational | 2021-12-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
One-year survival estimate is reported. Survival time is defined as time from registration to date of death from any cause and is estimated by the Kaplan-Meier method. Patients last known to be alive are censored at date of last contact. This analysis was planned to occur when all patients had been potentially followed for 1 year. On the basis of a 1-year survival rate of 60% from the Radiation Therapy Oncology Group (RTOG) esophageal database, 38 analyzable patients with a 1-year survival rate of 77.5% or better was needed for this trial to be deemed promising enough for development of a Phase III protocol (type I error of 0.05 and type II error of 0.20). (NCT00069953)
Timeframe: From registration to date of death or last follow-up. Analysis occurs after all patients have been potentially followed for 1 year.
| Intervention | percentage of participants (Number) |
|---|---|
| ChemoRT and Selective Surgery | 71 |
4 reviews available for fluorouracil and Minimal Disease, Residual
| Article | Year |
|---|---|
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases - Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy.
Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Antineoplastic Combined Chemotherapy Proto | 2021 |
Anal cancer treatment: current status and future perspectives.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; C | 2015 |
[Diagnosis and treatment of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endo | 2010 |
Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1996 |
41 trials available for fluorouracil and Minimal Disease, Residual
| Article | Year |
|---|---|
Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Circulating Tumor DNA; Clinical Trials | 2022 |
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast; Breast Neoplasms; Chemot | 2020 |
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy, Adjuvant; Disease-Free | 2017 |
Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.
Topics: Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Dose Fractionation, Radiation; Drug Admi | 2014 |
Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, | 2015 |
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, | 2015 |
Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiot | 2016 |
A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcin | 2016 |
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea | 2016 |
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea | 2016 |
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea | 2016 |
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea | 2016 |
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, | 2008 |
Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2008 |
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chem | 2009 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclo | 2010 |
Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Dist | 2011 |
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2012 |
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capec | 2012 |
Loco-regional failures in head and neck cancer: can they be effectively salvaged by nonsurgical therapeutic modalities?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Follow | 2003 |
Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2003 |
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; B | 2004 |
Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Mo | 2004 |
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colo | 2004 |
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cause of | 2004 |
Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di | 2005 |
Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylati | 2004 |
How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Docet | 2005 |
Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study.
Topics: Adult; Aged; Anal Canal; Antimetabolites, Antineoplastic; Chi-Square Distribution; Combined Modality | 2006 |
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool | 2006 |
Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dat | 2006 |
[Preventive chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer].
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Hu | 1995 |
Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1995 |
[Effect of prophylactic intra-arterial infusion of anticancer drugs on post hepatic resection for hepatic metastasis of colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administrati | 1994 |
Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protoc | 1995 |
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Epirubicin; Female; Fluorou | 1994 |
[Evaluation of prophylactic intra-hepatic-arterial infusion chemotherapy after resection of hepatic metastases from colorectal primaries].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Do | 1994 |
[Hepatic arterial infusion after hepatectomy for liver metastases of colorectal carcinoma to prevent residual hepatic recurrence].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Floxuridine; Flu | 1994 |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; He | 1994 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cisplatin; | 1996 |
[Evaluation of prophylactic hepatic arterial infusion chemotherapy after hepatectomy for metastases from colorectal cancer--the second report].
Topics: Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Hepatectomy; Hepatic Artery; Human | 1996 |
[The preventive effect of weekly high-dose 5-FU infusion (WHF) after resection of hepatic metastasis from colorectal cancer].
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; H | 1996 |
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Topics: Abdominal Neoplasms; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined | 2001 |
108 other studies available for fluorouracil and Minimal Disease, Residual
| Article | Year |
|---|---|
Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease- | 2022 |
YpN0 rectal cancer patients with sterilized lymph nodes after neoadjuvant chemoradiotherapy are of greater risk of recurrence.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, A | 2020 |
Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Disease-Free Surv | 2019 |
Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery.
Topics: Administration, Cutaneous; Aged; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Female; Fluorouracil | 2020 |
Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoembryonic | 2021 |
Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Female; | 2017 |
Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2017 |
Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Arteries; Celiac Artery; Chemo | 2018 |
Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2017 |
Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2018 |
Efficacy of anti-PD-1 therapy in a patient with brain metastasis of parotid carcinoma: A case report.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brain Ne | 2019 |
Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cohort Studies; F | 2019 |
Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2019 |
ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Disease-Free Survival; DNA-Binding Prot | 2019 |
Prognostic significance of pathological tumor response and residual nodal metastasis in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, | 2019 |
Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bile Duc | 2019 |
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Dose Fractionation, | 2013 |
Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradi | 2013 |
Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case.
Topics: Adenocarcinoma; Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; | 2014 |
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplati | 2016 |
[Adjuvant chemoradiotherapy in advanced gastric cancer: experience in 168 patients].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Fe | 2014 |
Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineopl | 2014 |
Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Chemora | 2014 |
Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cyclo | 2015 |
Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2014 |
Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Brea | 2015 |
Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2015 |
Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiothe | 2016 |
Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cis | 2015 |
[Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 2016 |
Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
Topics: Anaphase-Promoting Complex-Cyclosome; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Li | 2016 |
Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2016 |
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke | 2017 |
Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Disease-Free Surv | 2017 |
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 2017 |
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2008 |
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvan | 2008 |
Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Car | 2009 |
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; C | 2009 |
Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Squamous | 2009 |
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
Topics: AC133 Antigen; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2009 |
Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chi-Square Distribution; C | 2009 |
Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; CA-19-9 | 2011 |
Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biop | 2010 |
Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma | 2012 |
The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Decision | 2012 |
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; B | 2012 |
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor | 2011 |
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor | 2011 |
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor | 2011 |
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor | 2011 |
A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemoradiotherapy; De | 2012 |
The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2012 |
[Primary systemic therapy in breast cancer patients (2007-2010)].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; | 2011 |
Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Ch | 2012 |
A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2012 |
[Diffusion-weighted MR imaging in patients with rectal cancer: our initial experience].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Diffusion Magnetic Resonance Imagin | 2011 |
Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Chi-Square Distributi | 2012 |
Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Dose F | 2012 |
Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Ne | 2012 |
Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Topics: 3' Untranslated Regions; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 2013 |
Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choriocarcinoma, Non-gestat | 2012 |
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Topics: Adenocarcinoma; Aged; Anal Canal; Brazil; Chemoradiotherapy; Female; Fluorouracil; Humans; Male; Mic | 2013 |
Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2013 |
Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2013 |
Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 2003 |
Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2003 |
Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fe | 2005 |
Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2005 |
Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2005 |
Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Chemotherapy, Adjuvant; Combined M | 2005 |
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Combined Moda | 2005 |
Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Transformation, Neopl | 2006 |
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2006 |
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2006 |
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2006 |
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2006 |
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2006 |
Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation.
Topics: Adipose Tissue; Adult; Aged; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Intestin | 2006 |
Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2006 |
Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Do | 2007 |
[Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; | 2007 |
Tumour dormancy in breast cancer: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 2007 |
Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2007 |
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2007 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, | 1995 |
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cause o | 1995 |
Locally advanced breast cancer: is surgery warranted following chemotherapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1995 |
[Effects of 5-fluorouracil in shrinking residual gastric cancer: a case report].
Topics: Adenocarcinoma; Aged; Fluorouracil; Gastrectomy; Humans; Male; Neoplasm, Residual; Remission Inducti | 1995 |
[Home therapy approach in cancer patients-chemotherapy (case 2-1)].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorourac | 1994 |
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Adm | 1995 |
Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, | 1996 |
[Usefulness of continuous arterial infusion chemotherapy for post operative multiple recurrence and residual hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Administr | 1996 |
Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Topics: Adult; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 1996 |
Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modalit | 1997 |
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.
Topics: Antidotes; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Fluorourac | 1997 |
Breast conservation after induction chemotherapy for locally advanced breast cancer.
Topics: Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Al | 1997 |
[Liver abscess caused by hepatic artery infusion chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Colectomy; Colonic Neoplasms; Fluorouracil; Hepatec | 1997 |
[A case of stage IVb gastric cancer effectively treated by neoadjuvant chemotherapy and total gastrectomy with no residual tumor (R0)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cispla | 1997 |
[Intra-arterial preventive chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer].
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorou | 1998 |
p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Cell Dif | 1997 |
Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 1999 |
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; Antimetabolites, Antineoplastic; Combined Modality Thera | 1999 |
[Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms | 1999 |
Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Fluorouracil; Humans; Life | 1999 |
Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Diarrhea | 2000 |
The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 2000 |
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2000 |
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; | 2000 |
Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cohort Studies; Drug Administration Sche | 2000 |
Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouracil.
Topics: Anus Neoplasms; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Humans; Neop | 2000 |
A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2001 |
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Colectomy; | 2001 |
Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Female; Fluorouraci | 2002 |